Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the USA / NCT06146049
Starting soon Observational

Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder

NCT06146049 · tracked via the Priya Life Science USA tracker
Sponsor
Power Life Sciences Inc
Phase
Observational
Started
2024-12
Last updated
2023-11-24

Condition(s) studied

Post Traumatic Stress Disorder

Study summary

Participation in post traumatic stress disorder observational study serves as a crucial contribution to advancing medical knowledge and refining the care provided to individuals facing similar health challenges.

The primary objective centers on a meticulous examination of trial completion rates and voluntary withdrawals within this distinct patient population.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of post traumatic stress disorder * No prior treatment for post traumatic stress disorder * Willing and able to provide informed consent. Exclusion Criteria: * Enrolled in another research study * Psychiatric or behavioral illness * Inability to provide written informed consent

Primary outcome measure(s)

  • Rate of patients who decide to enroll in a post traumatic stress disorder clinical research. — 3 months
  • Number of post traumatic stress disorder study participants who remain in clinical study until completion. — 12 months

Trial sites (1)

FacilityCityRegionStatus
Power Life Sciences San Francisco California

More Power Life Sciences Inc. trials in the USA

A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa Starting soon
Assessing Patient Engagement in Keratoconus Clinical Research Starting soon
Understanding Patient Engagement Trends in TBI Clinical Research Starting soon
A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study Starting soon
Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials Starting soon

Other trials for the same condition

Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD) Recruiting
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) Recruiting
An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD Enrolling by invitation
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms Active, not recruiting
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06146049 on ClinicalTrials.gov ↗ ← All trials in the USA